This study examines the seroprevalence against SARS-CoV-2 in health care workers and patients at the Vienna General Hospital.
This study consists of 2 parts: a longitudinal study enrolling 3,000 health care
professionals at the Vienna General Hospital testing their antibody status 6 times over a
period of 12 months (Cohort A), and a serial cross-sectional study of 3,000 patients (i.e., a
total of 9,000 patients) admitted to the Vienna General Hospital for non-COVID-19-related
symptoms at 3 different time points during this pandemic (Cohort B).
Diagnostic Test: Laboratory Analyses
Storage of serum for SARS-CoV-2-antibodies and biomarkers
Cohort A:
Inclusion criteria:
- Physicians
- Nursing staff
- Midwives
- Medical-technical assistants (including medical, therapeutic and diagnostic healthcare
staff, and medical and nursing assistants)
- Administrative personnel with patient contact
Exclusion Criteria:
- Not employed at the Medical University of Vienna or the Vienna General Hospital
- No signed informed consent
Cohort B:
Inclusion Criteria:
● Patients with available residual serum samples
Exclusion Criteria:
● Serum samples from COVID-19 triage units at the Vienna General Hospital
Medical University of Vienna
Vienna, Austria
Investigator: Christian Hengstenberg, Univ.-Prof.
Contact: +43 1 40400
christian.hengstenberg@meduniwien.ac.at
Investigator:
Christian Hengstenberg, Univ.-Prof.
+43 1 40400 - 46140
christian.hengstenberg@meduniwien.ac.at
Thomas A Zelniker, DDr.
+43 1 40400 - 46140
thomas.zelniker@meduniwien.ac.at
Christian Hengstenberg, Univ.-Prof., Principal Investigator
Medical University of Vienna